Seminal vesicle antigen (SVA) activators encompass a diverse chemical class that directly or indirectly affects the activity of SVA. These activators are typically small molecules capable of traversing cellular membranes and interacting with various components within signaling pathways that converge on the regulation of SVA. The compounds engage with the complex intracellular machinery either by binding to receptors, influencing enzymatic activity, or altering the intracellular concentrations of secondary messengers. The primary mode of action for these activators involves the modulation of kinase activity, which in turn can lead to the phosphorylation states of proteins, including SVAs. This phosphorylation can change the function, localization, or interaction of SVAs with other cellular components, leading to an overall increase in their activity.
In addition to modifying kinase activity, some chemicals within this class function by manipulating gene expression. By affecting transcription factors or altering chromatin structure, these molecules can change the cellular levels of proteins that are directly involved in the regulation of SVA. Another subset of activators works by modulating cellular ion concentrations, such as calcium, which is a crucial second messenger in many signaling pathways. Alterations in calcium levels can activate or inhibit calcium-dependent protein kinases and phosphatases, which then exert control over the activity state of SVAs. The action of SVA activators is thus a result of a cascade of intracellular events that eventually lead to changes in the activity of SVA, demonstrating the complex and interconnected nature of cellular signaling pathways and how small molecules can exert significant control over protein function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
As a diacylglycerol analog, PMA activates protein kinase C (PKC), which could possibly phosphorylate and modulate SVA activity. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
This tyrosine kinase inhibitor could possibly result in altered kinase activity and potentially affect SVA through feedback regulation within signaling networks. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
This ionophore increases intracellular calcium levels, which could possibly activate calcium-sensitive signaling pathways affecting SVA. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
As a histone deacetylase inhibitor, this compound could possibly alter gene expression patterns, potentially increasing the expression of proteins that modulate SVA. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
This AMPK activator could possibly alter metabolic signaling pathways, potentially affecting SVA activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
As a PI3K inhibitor, wortmannin could possibly trigger compensatory regulatory mechanisms that modulate SVA activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
This mTOR inhibitor could possibly induce feedback mechanisms that lead to changes in protein synthesis and activity, potentially affecting SVA. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
This NF-κB inhibitor could possibly shift cellular signaling, potentially leading to changes in protein activity including SVA. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
This proteasome inhibitor could possibly result in increased levels of proteins due to inhibited degradation, potentially stabilizing proteins that regulate SVA. | ||||||